Sana Biotechnology, Inc. (SANA)
3.85
-0.07
(-1.79%)
USD |
NASDAQ |
Sep 04, 16:00
3.84
-0.01
(-0.26%)
After-Hours: 20:00
Sana Biotechnology SG&A Expense (TTM) : 44.71M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 44.71M |
| March 31, 2026 | 44.27M |
| December 31, 2025 | 44.30M |
| September 30, 2025 | 49.39M |
| June 30, 2025 | 53.15M |
| March 31, 2025 | 59.26M |
| December 31, 2024 | 64.04M |
| September 30, 2024 | 67.55M |
| June 30, 2024 | 72.68M |
| March 31, 2024 | 72.80M |
| December 31, 2023 | 73.30M |
| September 30, 2023 | 75.84M |
| June 30, 2023 | 72.17M |
| Date | Value |
|---|---|
| March 31, 2023 | 73.89M |
| December 31, 2022 | 71.56M |
| September 30, 2022 | 60.92M |
| June 30, 2022 | 58.84M |
| March 31, 2022 | 53.02M |
| December 31, 2021 | 50.41M |
| September 30, 2021 | 46.94M |
| June 30, 2021 | 33.50M |
| March 31, 2021 | 26.85M |
| December 31, 2020 | 15.02M |
| March 31, 2020 | 5.818M |
| December 31, 2019 | 5.818M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Twist Bioscience Corp. | 290.29M |
| Beam Therapeutics, Inc. | 125.40M |
| Prime Medicine, Inc. | 54.39M |
| Intellia Therapeutics, Inc. | 136.25M |
| Moderna, Inc. | 965.00M |